News - Myeloma Patients Europe

Latest News

Daratumumab increases progression-free survival in newly diagnosed myeloma patients ineligible for transplant

December 5, 2018

Data from the phase III MAIA clinical trial was presented yesterday as part of the Late-Breaking Abstracts Session during the 60th American Society of Hematology (ASH) Annual Meeting in San Diego.

New data presented at ASH 2018 from an ongoing phase I clinical trial of CAR T cell therapy in relapsed/refractory myeloma

December 4, 2018

Initial data from the ongoing phase I clinical trial of bb21217 (CRB-402) were presented at the 60th Annual Meeting of the American Society of Hematology (ASH). This is an investigational next-generation anti-BCMA CAR T cell…

WECAN workgroup of patient advocates and industry experts releases guiding principles for reasonable legal agreements between patient advocates and pharmaceutical companies

November 28, 2018

A collaboration between patient advocates and pharmaceutical companies usually requires both parties to sign contracts for different engagements such as for advisory, consultancy, collaborative or speaker engagements. These contracts usually cover areas such as confidentiality,…

ASH 2018 is about to kick-off in San Diego, USA

November 26, 2018

The annual meeting of the American Society of Haematology (ASH) 2018 starts this week (between 1 and 4 December) in San Diego, California.

Huge variations between countries in time for reimbursement decisions on new cancer drugs

October 20, 2018

European Society for Medical Oncology (ESMO), Munich (Germany) – Some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs following their approval…

Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risks

October 11, 2018

Complementary and alternative medicines are used by 1 in 2 patients before and during cancer treatments, however they are frequently associated with drug-drug interactions, a estudy at ESMO 2018 report.

Horizon2020 CARAMBA video on CAR-T cell therapy now available in five languages

October 1, 2018

At the recent European Haematology Association (EHA) Annual Congress 2018, Myeloma Patients Europe (MPE) and Video Journal of Hematological Oncology (VJHemOnc), filmed an interview with Dr Michael Hudecek (University of Würzburg, Germany) on the Horizon2020…

New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicines

August 21, 2018

A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by leading cancer specialists in Europe and North America, according to the announcement the European…

December

January 2025

February

MO
TU
WE
TH
FR
SA
SU

30
31
1
2
3
4
5

6
7
8
9
10
11
12

13
14
15
16
17
18
19

20
21
22
23
24
25
26

27
28
29
30
31
1
2

Events for January

31st

No Events

Latest News

January 2025

Events for January

1st

Events for January

2nd

Events for January

3rd

Events for January

4th

Events for January

5th

Events for January

6th

Events for January

7th

Events for January

8th

Events for January

9th

Events for January

10th

Events for January

11th

Events for January

12th

Events for January

13th

Events for January

14th

Events for January

15th

Events for January

16th

Events for January

17th

Events for January

18th

Events for January

19th

Events for January

20th

Events for January

21st

Events for January

22nd

Events for January

23rd

Events for January

24th

Events for January

25th

Events for January

26th

Events for January

27th

Events for January

28th

Events for January

29th

Events for January

30th

Events for January

31st

Myeloma Patients Europe AISBL

PopUp